PMID- 31456164 OWN - NLM STAT- MEDLINE DCOM- 20200210 LR - 20231213 IS - 2190-3883 (Electronic) IS - 1234-1983 (Print) IS - 1234-1983 (Linking) VI - 60 IP - 3-4 DP - 2019 Nov TI - MLPA as a complementary tool for diagnosis of chromosome 21 aberrations in childhood BCP-ALL. PG - 347-355 LID - 10.1007/s13353-019-00509-8 [doi] AB - Chromosome 21 abnormalities are the most frequent genetic findings in childhood B cell precursor acute lymphoblastic leukemia (BCP-ALL) cases. Majority of patients are effectively diagnosed with fluorescence in situ hybridization (FISH) and karyotyping; however, some cases may require additional tools to be used. Bone marrow samples of 373 childhood BCP-ALL patients were tested for chromosome 21 copy number variations (CNVs) with Multiplex Ligation-dependent Probe Amplification (MLPA) P327 array. Results from MLPA and cytogenetics were compared between groups according to the type of abnormality found on chromosome 21. Out the group of 235 patients, chromosome 21 multiplication was found by FISH assay in 56 cases (23.81%), ETV6-RUNX1 fusion in 34 (14.47%) and iAMP21 in 3 (1.28%) children, remaining 142 (60.43%) patients had no known chromosome 21 aberration. Median peak ratios of all tested probes in MLPA in aforementioned groups were 1.47 (IQR 1.28-1.77) vs. 1.00 (IQR 1.00-1.09) vs. 2.79 (IQR 1.97-2.83) vs. 1.00 (1.00-1.11), respectively. Aforementioned peak ratio of ETV6-RUNX1 fusion group was similar with patients of no known chromosome 21 aberration (p = 0.71). Interestingly, both groups differed from patients with chromosome 21 multiplication (p < 10(-5)) and with iAMP21 (p < 10(-5)). All cases of iAMP21 were correctly recognized by MLPA. MLPA seems to be good additional tool in the diagnostic process of chromosome 21 CNVs, especially in cases with iAMP21. FAU - Wrona, Ewa AU - Wrona E AUID- ORCID: 0000-0003-3247-924X AD - Department of Pediatrics, Oncology and Hematology, Medical University of Lodz, Lodz, Poland. ewawrona00@gmail.com. FAU - Braun, Marcin AU - Braun M AD - Department of Pathology, Chair of Oncology, Medical University of Lodz, Lodz, Poland. FAU - Pastorczak, Agata AU - Pastorczak A AD - Department of Pediatrics, Oncology and Hematology, Medical University of Lodz, Lodz, Poland. FAU - Taha, Joanna AU - Taha J AD - Department of Pediatrics, Oncology and Hematology, Medical University of Lodz, Lodz, Poland. FAU - Lejman, Monika AU - Lejman M AD - Department of Pediatric Hematology and Oncology, Medical University of Lublin, Lublin, Poland. FAU - Kowalczyk, Jerzy AU - Kowalczyk J AD - Department of Pediatric Hematology and Oncology, Medical University of Lublin, Lublin, Poland. FAU - Fendler, Wojciech AU - Fendler W AD - Department of Biostatistics & Translational Medicine, Medical University of Lodz, Lodz, Poland. AD - Department of Radiation Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. FAU - Mlynarski, Wojciech AU - Mlynarski W AD - Department of Pediatrics, Oncology and Hematology, Medical University of Lodz, Lodz, Poland. LA - eng GR - 2014/13/N/NZ5/03660/National Science Centre/ GR - STRATEGMED3/304586/5/2017/National Center of Research and Development/ PT - Journal Article DEP - 20190827 PL - England TA - J Appl Genet JT - Journal of applied genetics JID - 9514582 RN - 0 (Core Binding Factor Alpha 2 Subunit) RN - 0 (Proto-Oncogene Proteins c-ets) RN - 0 (RUNX1 protein, human) RN - 0 (Repressor Proteins) SB - IM MH - Child MH - Child, Preschool MH - *Chromosome Aberrations MH - Chromosomes, Human, Pair 21/*genetics MH - Core Binding Factor Alpha 2 Subunit/genetics MH - Cytodiagnosis MH - DNA Copy Number Variations/*genetics MH - Female MH - Humans MH - In Situ Hybridization, Fluorescence MH - Karyotyping MH - Male MH - Precursor B-Cell Lymphoblastic Leukemia-Lymphoma/*diagnosis/genetics/pathology MH - Proto-Oncogene Proteins c-ets/genetics MH - Repressor Proteins/genetics MH - Translocation, Genetic/genetics MH - ETS Translocation Variant 6 Protein PMC - PMC6803575 OTO - NOTNLM OT - CNVs OT - Childhood BCP-ALL OT - ETV6-RUNX1 fusion OT - FISH assay OT - Intrachromosomal amplification of chromosome 21 (iAMP21) OT - MLPA COIS- The authors declare that they have no conflict of interest. EDAT- 2019/08/29 06:00 MHDA- 2020/02/11 06:00 PMCR- 2019/08/27 CRDT- 2019/08/29 06:00 PHST- 2019/04/04 00:00 [received] PHST- 2019/07/23 00:00 [accepted] PHST- 2019/07/10 00:00 [revised] PHST- 2019/08/29 06:00 [pubmed] PHST- 2020/02/11 06:00 [medline] PHST- 2019/08/29 06:00 [entrez] PHST- 2019/08/27 00:00 [pmc-release] AID - 10.1007/s13353-019-00509-8 [pii] AID - 509 [pii] AID - 10.1007/s13353-019-00509-8 [doi] PST - ppublish SO - J Appl Genet. 2019 Nov;60(3-4):347-355. doi: 10.1007/s13353-019-00509-8. Epub 2019 Aug 27.